Company profile: Genfit
1.1 - Company Overview
Company description
- Provider of innovative therapeutic and diagnostic solutions for metabolic and liver-related diseases, dedicated to discovery and development in areas with considerable unmet medical needs where approved treatments are lacking; a late-stage biopharmaceutical company.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Genfit
Embark Biotech
HQ: Denmark
Website
- Description: Provider of biotech research identifying novel cell surface receptors that physiologically regulate fat tissue calorie-burning and glucose and lipid uptake; founded in 2017 and headquartered in Copenhagen, Denmark.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Embark Biotech company profile →
USGI Medical
HQ: United States
Website
- Description: Provider of incisionless surgical technologies for gastrointestinal procedures, offering the Incisionless Operating Platform to address GI procedural challenges; the POSE2.0 endoscopic gastroplasty using Snowshoe Suture Anchors to provide gastric restriction without removing part of the stomach; and tools including the g-Cath Tissue Anchor Delivery Catheter, g-Prox EZ Endoscopic Grasper, and Transport Endoscopic Guide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full USGI Medical company profile →
PhaseBio
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical drug development targeting cardiovascular, endocrine, and metabolic disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PhaseBio company profile →
Akero Therapeutics
HQ: United States
Website
- Description: Provider of investigational therapies for metabolic dysfunction-associated steatohepatitis (MASH), including efruxifermin (EFX), which mimics FGF21 to regulate metabolic pathways and cellular processes; clinical trials (SYNCHRONY, SYMMETRY, HARMONY, BALANCED) evaluating EFX; pipeline development for MASH and other serious metabolic diseases; and manufacturing partnerships with Boehringer-Ingelheim and Vetter Pharma.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Akero Therapeutics company profile →
Akarna Therapeutics
HQ: United States
Website
- Description: Provider of biopharmaceutical research and development of novel small molecule therapeutics targeting inflammatory and fibrotic diseases, including a non-bile acid FXR agonist for nonalcoholic steatohepatitis (NASH), aiming to deliver best-in-class treatments for chronic liver diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Akarna Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Genfit
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Genfit
2.2 - Growth funds investing in similar companies to Genfit
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Genfit
4.2 - Public trading comparable groups for Genfit
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →